This inventor holds 2 USPTO granted patents. Top assignee: Takeda Pharmaceutical Company Limited. Active years: 2007-2010.
Location History:
- Inashiki-gun, JP (2007)
- Ibaraki, JP (2010)
Company Filing History:
Years Active: 2007-2010
Title: Michiko Abe: Innovator in GPR8 Ligand Development
Introduction
Michiko Abe is a prominent inventor based in Ibaraki, Japan. She has made significant contributions to the field of biochemistry, particularly in the development of ligands for GPR8. With a total of 2 patents, her work is paving the way for advancements in drug development.
Latest Patents
Abe's latest patents include innovative approaches to creating ligands for GPR8. The first patent focuses on polypeptides capable of binding to GPR8, its amides, esters, or salts, along with the DNA encoding for such polypeptides. This invention is particularly useful in developing receptor-binding assay systems, which can be utilized for screening candidate compounds for drugs aimed at obesity, appetite stimulation, and prolactin production inhibition. The second patent reiterates the importance of these ligands in the same context, emphasizing their role in therapeutic applications.
Career Highlights
Michiko Abe is currently associated with Takeda Pharmaceutical Company Limited, where she continues her research and development efforts. Her work is instrumental in advancing the understanding of GPR8 and its potential applications in medicine.
Collaborations
Abe collaborates with notable colleagues such as Masaaki Mori and Yukio Shimomura, contributing to a dynamic research environment that fosters innovation and discovery.
Conclusion
In summary, Michiko Abe is a trailblazer in the field of biochemistry, with her patents on GPR8 ligands showcasing her innovative spirit and dedication to improving therapeutic options. Her contributions are vital to the ongoing research in obesity and appetite regulation.